Omnicell (OMCL) Short-term Investments (2010 - 2023)
Omnicell's (OMCL) quarterly Short-term Investments came in at $46.1 million in Q2 2023, up 11.07% year-over-year from $41.5 million in Q2 2022, and up 5.3% quarter-over-quarter from $43.8 million in Q1 2023.
Analysis
Omnicell (OMCL) Short-term Investments (2010 - 2023) Analysis & Trends
Omnicell (OMCL) has reported Short-term Investments for 8 consecutive years, with $46.1 million the latest figure, recorded in Q2 2023.
- On a quarterly basis, Short-term Investments rose 11.07% year-over-year to $46.1 million in Q2 2023; TTM through Jun 2023 was $46.1 million, a 11.07% increase from a year earlier, with the FY2022 full-year figure at $44.4 million, up 52.84% from the prior year.
- Short-term Investments was $46.1 million for Q2 2023 at Omnicell, up from $43.8 million in the prior quarter.
- Over five years, Short-term Investments peaked at $46.4 million in Q3 2022 and troughed at $29.1 million in Q4 2021.
- A 5-year average of $35.2 million and a median of $31.5 million in 2021 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments slipped 10.33% in 2021 and soared 56.12% in 2022, its largest moves.
- Over 5 years, Short-term Investments stood at $29.5 million in 2019, then increased by 9.76% to $32.4 million in 2020, then retreated by 10.33% to $29.1 million in 2021, then surged by 52.84% to $44.4 million in 2022, then grew by 3.84% to $46.1 million in 2023.
- The last three Short-term Investments figures came in at $46.1 million (Q2 2023), $43.8 million (Q1 2023), and $44.4 million (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 46.12 Mn |
| Mar 31, 2023 | 43.80 Mn |
| Dec 31, 2022 | 44.41 Mn |
| Sep 30, 2022 | 46.39 Mn |
| Jun 30, 2022 | 41.52 Mn |
| Mar 31, 2022 | 30.15 Mn |
| Dec 31, 2021 | 29.06 Mn |
| Sep 30, 2021 | 29.72 Mn |
| Jun 30, 2021 | 29.98 Mn |
| Mar 31, 2021 | 31.48 Mn |
| Dec 31, 2020 | 32.40 Mn |
| Sep 30, 2020 | 32.79 Mn |
| Jun 30, 2020 | 30.90 Mn |
| Mar 31, 2020 | 29.79 Mn |
| Dec 31, 2019 | 29.52 Mn |
| Mar 31, 2012 | 8.12 Mn |
| Dec 31, 2011 | 8.11 Mn |
| Sep 30, 2011 | 8.10 Mn |
| Dec 31, 2010 | 8.07 Mn |